AimedBio
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Mk Tower 67 Jeongui-ro Songpa-gu 11F, Se...Phone Number
+82 262850743Website
www.aimedbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About AimedBio
AimedBio is a South Korean biotechnology company dedicated to developing innovative antibody-based therapies, particularly antibody-drug conjugates (ADCs) and bispecific antibodies, to address challenging brain diseases. Originating as a spin-off from Samsung Medical Center, the company leverages its proprietary patient-derived cell-based antibody discovery technology and translational research expertise to create targeted treatments for conditions like glioblastoma, Alzheimer's, and Parkinson's disease. AimedBio's approach combines multi-omics and AI-driven big data analysis to enhance drug discovery and development. Collaborations with entities like Samsung Biologics and GeneQuantum Healthcare further bolster its efforts in advancing next-generation biotherapeutics.Explore more
AimedBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AimedBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if AimedBio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at AimedBio
Check out if AimedBio is spiking on competitors!
Click to see if AimedBio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once AimedBio has new funding data
Product Launch: Get notified when AimedBio launches new products
AimedBio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AimedBio recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined AimedBio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
AimedBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AimedBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AimedBio.
AimedBio Tech Stack
AimedBio News & Media
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio
Boehringer and AimedBio partner to develop novel antibody-drug conjugate therapy aiming to transform the treatment landscape for a broad range of cancers.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AimedBio
Sign Up For FreeTo access detailed company insights
AimedBio is a South Korean biotechnology company dedicated to developing innovative antibody-based therapies, particularly antibody-drug conjugates (ADCs) and bispecific antibodies, to address challenging brain diseases. Originating as a spin-off from Samsung Medical Center, the company leverages its proprietary patient-derived cell-based antibody... Read More
